Trial reportPsychophysiology2026
Nocturnal Risk Assessment and Its Association With Anxiety Symptoms.
Trial report in Psychophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human risk assessment (RA), the attentional and behavioral activities involved in detecting and analyzing threat, is feasibly enhanced at night to protect against hidden danger. However, this enhanced RA at night might come at a cost and thus signal increased risk for anxiety disorders. To test the hypothesis that the nighttime enhances RA and its associations with anxiety, the current study randomly assigned healthy volunteers (N = 87, Mean age = 22.4; 69% Female) to visit the laboratory at day or night. Participants completed a novel task that presented images depicting neutral content, injury threat (e.g., weapon) or infection threat (e.g., person sneezing). Each image was followed by a lottery decision. The task estimated RA's attentional component as threat-induced bradycardia-cardiac deceleration to threat images. RA's behavioral component was estimated as threat-induced risk aversion-decrease in risky choice following threat images. Anxiety symptoms were self-reported on the Depression, Anxiety, and Stress Scale (DASS-21). The cardiac results partially supported the "nocturnal enhancement" hypothesis: (1) The night but not the day group exhibited a sustained, non-habituating pattern of threat-induced bradycardia to infection threat images. (2) In the night but not the day group, individuals with higher bradycardia to infection images had a higher likelihood of elevated anxiety. Contrary to predictions, bradycardia to injury threat and risk aversion metrics, as well as their relations to anxiety symptoms, were not higher at night. Overall, time-of-day is shown to be an important variable to consider in studies of human threat responses and anxiety disorder risk. Based on our findings, the intuitive idea that humans have elevated RA at night is not straightforward; instead, the nighttime may selectively activate attentional orienting (vis-à-vis bradycardia) to ambiguous stimuli like those signaling risk of illness, with these nocturnal enhancements being subject to individual differences in anxiety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.